Buzz Stocks: Tyco International plc, Sunedison Inc, and Oncomed Pharmaceuticals Inc

Today's stocks to watch include Tyco International plc (Ireland) Ordinary Share (TYC), Sunedison Inc (SUNE), and Oncomed Pharmaceuticals Inc (OMED)

Jan 25, 2016 at 9:56 AM
facebook X logo linkedin

U.S. stocks are backpedaling this morning, following the bearish lead of crude oil. Among the equities in focus are security systems specialist Tyco International plc (Ireland) Ordinary Share (NYSE:TYC), alternative energy issue Sunedison Inc (NYSE:SUNE), and drugmaker Oncomed Pharmaceuticals Inc (NASDAQ:OMED). 

  • TYC has surged 7.2% to trade at $32.79, after the Ireland-based company announced it will merge with Johnson Controls Inc (NYSE:JCI) -- with the latter set to move its legal and global headquarters overseas to lower its taxes. JCI will own approximately 56% of the combined entity, and will receive a cash consideration of nearly $4 billion once the deal closes. Tyco International plc put buyers may not be so happy with this morning's sharp gains. During the past two weeks across the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), traders have bought to open nearly six times as many puts as calls. The resultant put/call volume ratio of 5.93 ranks in the 88th percentile of its annual range.
  • SUNE is making waves this morning, amid reports that the firm's joint venture talks with Gamesa have stalled. Also, according to The Wall Street Journal, Sunedison Inc has decided to give a seat on its board to Greenlight Capital, which owns an 8% stake in the alternative energy company. The headlines have sent the stock 7% higher out of the gate at $2.83, but its year-to-date deficit still stands at a daunting 44%. On the sentiment front, short sellers have been hitting the exits, with short interest falling 10.7% during the latest reporting period. Nonetheless, over 43% of SUNE's float remains sold short, as bears hold out hope for additional losses.
  • OMED has plummeted 44.5% at $9.74, and is fresh off an all-time low of $9.65, after independent experts told the drugmaker its pancreatic cancer treatment will likely miss its main goal in a mid-stage trial. While shareholders may be rattled, short sellers are probably dancing in the streets. Over 19% of Oncomed Pharmaceuticals Inc's float is sold short, representing three weeks' worth of trading activity, at the stock's average daily volumes. Separately, the shares may be in danger of downgrades, as 80% of covering analysts rate OMED a "strong buy," with not a single "sell" opinion to be found.

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI